0001402296-13-000002.txt : 20131001
0001402296-13-000002.hdr.sgml : 20131001
20130930173739
ACCESSION NUMBER: 0001402296-13-000002
CONFORMED SUBMISSION TYPE: D/A
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20131001
DATE AS OF CHANGE: 20130930
EFFECTIVENESS DATE: 20131001
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: PaxVax Inc
CENTRAL INDEX KEY: 0001402296
IRS NUMBER: 113780505
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D/A
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-151042
FILM NUMBER: 131124282
BUSINESS ADDRESS:
STREET 1: 3985A SORRENTO VALLEY BOULEVARD
CITY: SAN DIEGO
STATE: ca
ZIP: 92121
BUSINESS PHONE: 858-450-9595
MAIL ADDRESS:
STREET 1: 3985A SORRENTO VALLEY BOULEVARD
CITY: SAN DIEGO
STATE: ca
ZIP: 92121
D/A
1
primary_doc.xml
X0707
D/A
LIVE
0001402296
PaxVax Inc
3985A SORRENTO VALLEY BOULEVARD
SAN DIEGO
CA
CALIFORNIA
92121
858-450-9595
DELAWARE
None
None
Corporation
true
Kenneth
J.
Kelley
c/o PaxVax, Inc.
3985A Sorrento Valley Boulevard
San Diego
CA
CALIFORNIA
92121
Executive Officer
Director
Henry
G.
Coit, Jr.
c/o PaxVax, Inc.
3985A Sorrento Valley Boulevard
San Diego
CA
CALIFORNIA
92121
Director
Howard
B.
Rosen
c/o PaxVax, Inc.
3985A Sorrento Valley Boulevard
San Diego
CA
CALIFORNIA
92121
Director
Richard
Tong
c/o PaxVax, Inc.
3985A Sorrento Valley Boulevard
San Diego
CA
CALIFORNIA
92121
Director
Phil
Russell
c/o PaxVax, Inc.
3985A Sorrento Valley Boulevard
San Diego
CA
CALIFORNIA
92121
Director
Pharmaceuticals
Decline to Disclose
- 06b
true
0001402296-10-000001
2010-11-10
false
true
true
true
true
Securities offered consist of promissory notes convertible into shares of convertible preferred stock and the common stock underlying the convertible preferred stock.
false
0
35106472
35106472
0
false
19
0
0
0
false
PaxVax Inc
Kenneth Kelley
Kenneth Kelley
Chief Executive Officer
2013-09-30